Suppr超能文献

预处理通过亚型特异性 KATP 通道激活来防止人内皮细胞缺血再灌注损伤,并且可以通过抑制线粒体通透性转换孔来模拟。

Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore.

机构信息

Centre for Clinical Pharmacology, University College London, The Rayne Institute, 5 University Street, London, UK.

出版信息

Eur Heart J. 2011 May;32(10):1266-74. doi: 10.1093/eurheartj/ehr041. Epub 2011 Feb 28.

Abstract

AIMS

Intermittent early reperfusion (ischaemic postconditioning; PostC) reduces ischaemia-reperfusion (IR) injury. Using an in vivo model of endothelial IR injury in humans, we sought to determine the role of K(ATP) channels in PostC and whether inhibition of the mitochondrial permeability transition pore (mPTP) at the onset of reperfusion protected against endothelial IR injury.

METHODS AND RESULTS

Endothelial function (EF) in healthy volunteers was assessed using vascular ultrasound to measure the percentage increase in the diameter of the brachial artery in response to reactive hyperaemia [flow-mediated dilatation (FMD)]. In resistance vessels, venous occlusion plethysmography was used to measure the dilator response to acetylcholine (ACh) [area under ACh dose-response curve (ACh AUC)]. Measurements were made before and after IR injury. Ischaemic postconditioning consisted of three 10 s cycles of alternating ischaemia and reperfusion in the first minute of reperfusion. Oral glibenclamide and glimepiride were used to determine the role of K(ATP) channel subtypes in PostC. Intra-arterial cyclosporine was used to determine the role of mPTP in endothelial IR injury. Ischaemia-reperfusion reduced EF in the brachial artery (FMD 7.1 ± 0.9% pre-IR, 2.8 ± 0.4% post-IR; P < 0.001) and resistance vessels [ACh AUC (×10(4)) 2.1 ± 0.4 pre-IR, 1.5 ± 0.2 post-IR; P < 0.05]. Ischaemic postconditioning preserved EF in the brachial artery [FMD 6.8 ± 0.9% (P < 0.001 vs. post-IR)] and resistance vessels [ACh AUC (×10(4)) 1.9 ± 0.2 (P < 0.001 vs. post-IR)]. Protection by PostC was abolished by glibenclamide in the brachial artery [FMD 3.3 ± 0.2% (P < 0.001 vs. post-IR + PostC)] and in resistance vessels [ACh AUC (×10(4)) 1.1 ± 0.2 (P < 0.001 vs. post-IR + PostC)], whereas glimepiride had no effect. Cyclosporine preserved EF after IR injury in the resistance vessels [ACh AUC (×10(4)) 1.4 ± 0.2 post-IR vs. 2.2 ± 0.3 post-IR + cyclosporine; P < 0.05].

CONCLUSION

Protection by PostC against endothelial IR injury in humans depends on K(ATP) channel activation and is mimicked by inhibition of the mPTP at reperfusion.

摘要

目的

间歇性早期再灌注(缺血后处理;PostC)可减轻缺血再灌注(IR)损伤。我们在人类内皮 IR 损伤的体内模型中,旨在确定 K(ATP)通道在 PostC 中的作用,以及再灌注时抑制线粒体通透性转换孔(mPTP)是否能防止内皮 IR 损伤。

方法和结果

健康志愿者的内皮功能(EF)通过血管超声测量肱动脉直径对反应性充血的增加百分比来评估[血流介导的扩张(FMD)]。在阻力血管中,使用静脉闭塞体积描记法测量乙酰胆碱(ACh)的扩张反应[ACh 剂量反应曲线下面积(ACh AUC)]。在 IR 损伤前后进行测量。缺血后处理包括在再灌注的第 1 分钟内进行三个 10 秒的缺血和再灌注循环。口服格列本脲和格列美脲用于确定 K(ATP)通道亚型在 PostC 中的作用。动脉内环孢素用于确定 mPTP 在内皮 IR 损伤中的作用。缺血再灌注降低了肱动脉的 EF(FMD:7.1 ± 0.9%,预 IR;2.8 ± 0.4%,post-IR;P < 0.001)和阻力血管[ACh AUC(×10(4)):2.1 ± 0.4,预 IR;1.5 ± 0.2,post-IR;P < 0.05]。缺血后处理可保护肱动脉的 EF[FMD:6.8 ± 0.9%(P < 0.001,post-IR)]和阻力血管[ACh AUC(×10(4)):1.9 ± 0.2(P < 0.001,post-IR)]。在肱动脉[FMD:3.3 ± 0.2%(P < 0.001,post-IR + PostC)]和阻力血管[ACh AUC(×10(4)):1.1 ± 0.2(P < 0.001,post-IR + PostC)]中,格列本脲可消除 PostC 对 IR 损伤的保护作用,而格列美脲则没有影响。环孢素可防止 IR 损伤后阻力血管中的 EF 下降[ACh AUC(×10(4)):post-IR 时为 1.4 ± 0.2,post-IR + 环孢素时为 2.2 ± 0.3;P < 0.05]。

结论

PostC 对人类内皮 IR 损伤的保护作用依赖于 K(ATP)通道的激活,并可通过再灌注时抑制 mPTP 来模拟。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验